BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 8393239)

  • 1. Replication of the A7(74) strain of Semliki Forest virus is restricted in neurons.
    Fazakerley JK; Pathak S; Scallan M; Amor S; Dyson H
    Virology; 1993 Aug; 195(2):627-37. PubMed ID: 8393239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of Semliki Forest virus encephalitis.
    Fazakerley JK
    J Neurovirol; 2002 Dec; 8 Suppl 2():66-74. PubMed ID: 12491154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenicity of the A7, M9 and L10 strains of Semliki Forest virus for weanling mice and primary mouse brain cell cultures.
    Gates MC; Sheahan BJ; O'Sullivan MA; Atkins GJ
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2365-73. PubMed ID: 2997371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis.
    Amor S; Scallan MF; Morris MM; Dyson H; Fazakerley JK
    J Gen Virol; 1996 Feb; 77 ( Pt 2 )():281-91. PubMed ID: 8627232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus tropism, distribution, persistence and pathology in the corpus callosum of the Semliki Forest virus-infected mouse brain: a novel system to study virus-oligodendrocyte interactions.
    Fazakerley JK; Cotterill CL; Lee G; Graham A
    Neuropathol Appl Neurobiol; 2006 Aug; 32(4):397-409. PubMed ID: 16866985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice.
    Vähä-Koskela MJ; Kallio JP; Jansson LC; Heikkilä JE; Zakhartchenko VA; Kallajoki MA; Kähäri VM; Hinkkanen AE
    Cancer Res; 2006 Jul; 66(14):7185-94. PubMed ID: 16849565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplication of virulent and demyelinating Semliki Forest virus in the mouse central nervous system: consequences in BALB/c and SJL mice.
    Smyth JM; Sheahan BJ; Atkins GJ
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2575-83. PubMed ID: 2174955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semliki Forest virus induced, immune mediated demyelination: the effect of irradiation.
    Fazakerley JK; Webb HE
    Br J Exp Pathol; 1987 Feb; 68(1):101-13. PubMed ID: 3028463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin synthesis in nude (nu/nu), nu/+ and reconstituted nu/nu mice infected with a demyelinating strain of Semliki Forest virus.
    Suckling AJ; Jagelman S; Webb HE
    Clin Exp Immunol; 1982 Feb; 47(2):283-8. PubMed ID: 6280913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Semliki Forest virus E2 gene as a virulence determinant.
    Santagati MG; Määttä JA; Itäranta PV; Salmi AA; Hinkkanen AE
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():47-52. PubMed ID: 7844541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of defective interfering virus in the brains of mice by an avirulent, in contrast with a virulent, strain of Semliki forest virus.
    Woodward CG; Smith H
    Br J Exp Pathol; 1975 Aug; 56(4):363-72. PubMed ID: 1174462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations of reasons for the avirulence of the A7 strain of Semliki Forest virus in adult mice.
    Woodward CG; Marshall ID; Smith H
    Br J Exp Pathol; 1977 Dec; 58(6):616-24. PubMed ID: 607983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virulent and avirulent strains of Semliki Forest virus show similar cell tropism for the murine central nervous system but differ in the severity and rate of induction of cytolytic damage.
    Balluz IM; Glasgow GM; Killen HM; Mabruk MJ; Sheahan BJ; Atkins GJ
    Neuropathol Appl Neurobiol; 1993 Jun; 19(3):233-9. PubMed ID: 8395026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstitution of Semliki forest virus infected mice, induces immune mediated pathological changes in the CNS.
    Fazakerley JK; Amor S; Webb HE
    Clin Exp Immunol; 1983 Apr; 52(1):115-20. PubMed ID: 6305540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cycloleucine on SFV A7(74) infection in mice.
    Amor S; Webb HE
    Br J Exp Pathol; 1987 Apr; 68(2):225-35. PubMed ID: 3034321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two mutations in the envelope glycoprotein E2 of Semliki Forest virus affecting the maturation and entry patterns of the virus alter pathogenicity for mice.
    Glasgow GM; Sheahan BJ; Atkins GJ; Wahlberg JM; Salminen A; Liljeström P
    Virology; 1991 Dec; 185(2):741-8. PubMed ID: 1660202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further studies of macrophages in relationship to avirulent Semliki Forest virus infections.
    Oaten SW; Jagelman S; Webb HE
    Br J Exp Pathol; 1980 Apr; 61(2):150-5. PubMed ID: 6775662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenesis of avirulent Semliki Forest virus infections in athymic nude mice.
    Jagelman S; Suckling AJ; Webb HE; Bowen FT
    J Gen Virol; 1978 Dec; 41(3):599-607. PubMed ID: 745010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aurothiolates enhance the replication of Semliki Forest virus in the CNS and the exocrine pancreas.
    Scallan MF; Fazakerley JK
    J Neurovirol; 1999 Aug; 5(4):392-400. PubMed ID: 10463861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of defective-interfering Semliki Forest virus on the histopathology of infection with virulent Semliki Forest virus in mice.
    Crouch CF; Mackenzie A; Dimmock NJ
    J Infect Dis; 1982 Sep; 146(3):411-6. PubMed ID: 6286798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.